Bundamedik Tbk vs Abadi Lestari Indonesia Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Abadi Lestari Indonesia Tbk. trades at Rp3,260 (market cap 10.06T, 688.4K 24h volume). The key difference: Abadi Lestari Indonesia Tbk. is far larger — about 6.7× Bundamedik Tbk's market cap, and Abadi Lestari Indonesia Tbk. is more actively traded (688.4K versus 536.7K). Which is the better fit depends on your goals.
| BMHS | RLCO | |
|---|---|---|
Market Cap | 1.51T | 10.06T |
Volume | 536.7K | 688.4K |
Lot | 5.37K | 6.88K |
Turnover | 93.41M | 2.25B |
Average Price | 174.05 | 3,273.17 |
Value | 93.41M | 2.25B |
Indicative Equilibrium Price | 176 | 3,260 |
Indicative Equilibrium Volume | 100 | 15 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.
Read more on RLCO →